These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 24023259)

  • 21. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.
    Lorenzi S; Mattei F; Sistigu A; Bracci L; Spadaro F; Sanchez M; Spada M; Belardelli F; Gabriele L; Schiavoni G
    J Immunol; 2011 May; 186(9):5142-50. PubMed ID: 21441457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.
    Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSK-3β in Dendritic Cells Exerts Opposite Functions in Regulating Cross-Priming and Memory CD8 T Cell Responses Independent of β-Catenin.
    Fu C; Wang J; Ma T; Yin C; Zhou L; Clausen BE; Mi QS; Jiang A
    Vaccines (Basel); 2024 Sep; 12(9):. PubMed ID: 39340067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
    Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
    Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity.
    Böttcher JP; Schanz O; Wohlleber D; Abdullah Z; Debey-Pascher S; Staratschek-Jox A; Höchst B; Hegenbarth S; Grell J; Limmer A; Atreya I; Neurath MF; Busch DH; Schmitt E; van Endert P; Kolanus W; Kurts C; Schultze JL; Diehl L; Knolle PA
    Cell Rep; 2013 Mar; 3(3):779-95. PubMed ID: 23499443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.
    Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC
    J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo.
    Luckashenak N; Schroeder S; Endt K; Schmidt D; Mahnke K; Bachmann MF; Marconi P; Deeg CA; Brocker T
    Immunity; 2008 Apr; 28(4):521-32. PubMed ID: 18387832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of alpha-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo.
    Simkins HM; Hyde E; Farrand KJ; Ong ML; Degli-Esposti MA; Hermans IF; Ronchese F
    J Leukoc Biol; 2011 May; 89(5):753-62. PubMed ID: 21297009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells use endocytic pathway for cross-priming class Ib MHC-restricted CD8alphaalpha+TCRalphabeta+ T cells with regulatory properties.
    Smith TR; Tang X; Maricic I; Garcia Z; Fanchiang S; Kumar V
    J Immunol; 2009 Jun; 182(11):6959-68. PubMed ID: 19454693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I interferon activates MHC class I-dressed CD11b
    Duong E; Fessenden TB; Lutz E; Dinter T; Yim L; Blatt S; Bhutkar A; Wittrup KD; Spranger S
    Immunity; 2022 Feb; 55(2):308-323.e9. PubMed ID: 34800368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells.
    Moriya K; Wakabayashi A; Shimizu M; Tamura H; Dan K; Takahashi H
    Cancer Immunol Immunother; 2010 Jul; 59(7):1083-95. PubMed ID: 20221597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymic but not splenic CD8⁺ DCs can efficiently cross-prime T cells in the absence of licensing factors.
    Dresch C; Ackermann M; Vogt B; de Andrade Pereira B; Shortman K; Fraefel C
    Eur J Immunol; 2011 Sep; 41(9):2544-55. PubMed ID: 21748731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
    Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
    Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.